Predict your next investment

HEALTHCARE | Biotechnology
lumos-pharma.com

See what CB Insights has to offer

Founded Year

2011

Stage

Reverse Merger | IPO

Total Raised

$48M

About Lumos Pharma

Lumos Pharma is a clinical stage biopharmaceutical company committed to identifying, developing and commercializing therapies for patients and families living with rare diseases. Lumos strives to work with all stakeholders in the rare disease field, from universities to patient organizations.

Lumos Pharma Headquarter Location

4200 Marathon Blvd. Suite 200

Austin, Texas, 78756,

United States

512-215-2630

Latest Lumos Pharma News

Lumos Pharma to Participate in Upcoming Investor Conferences

Nov 11, 2021

To schedule a meeting with management during the conferences, please contact your salesperson at the respective firm. Webcasts for each presentation will be available on the Company’s website under “ Events & Presentations ” in the Investors & Media section. About Lumos Pharma Lumos Pharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of therapeutics for rare diseases. Lumos Pharma was founded and is led by a management team with longstanding experience in rare disease drug development and received early funding from leading healthcare investors, including Deerfield Management, a fund managed by Blackstone Life Sciences, Roche Venture Fund, New Enterprise Associates (NEA), Santé Ventures, and UCB. Lumos Pharma’s lead therapeutic candidate is LUM-201, an oral growth hormone stimulating small molecule, currently being evaluated in a Phase 2 clinical trial, the OraGrowtH210 Trial, and a PK/PD trial, the OraGrowtH212 Trial, for the treatment of Pediatric Growth Hormone Deficiency (PGHD). If approved by the FDA, LUM-201 would provide an orally administered alternative to recombinant growth hormone injections that PGHD patients otherwise endure for many years of treatment. LUM-201 has received Orphan Drug Designation in both the US and EU. For more information, please visit https://lumos-pharma.com/ . Investor & Media Contact:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Lumos Pharma

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Lumos Pharma is included in 1 Expert Collection, including Biopharmaceuticals.

B

Biopharmaceuticals

14,140 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Lumos Pharma Patents

Lumos Pharma has filed 8 patents.

The 3 most popular patent topics include:

  • Rare diseases
  • Syndromes
  • Transcription factors
patents chart

Application Date

Grant Date

Title

Related Topics

Status

9/20/2018

1/26/2021

Rare diseases, Syndromes, Pediatrics, Transcription factors, Growth hormones

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

9/20/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

1/26/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Rare diseases, Syndromes, Pediatrics, Transcription factors, Growth hormones

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Lumos Pharma Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Lumos Pharma Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.